Affimed NV
NASDAQ:AFMD
Wall Street
Price Targets
AFMD Price Targets Summary
Affimed NV
According to Wall Street analysts, the average 1-year price target for
AFMD
is 22.95 USD
with a low forecast of 5.05 USD and a high forecast of 63 USD.
AFMD Last Price Targets
Affimed NV
The latest public price target was made on Apr 1, 2024 by
Bradley Canino
from
Stifel Nicolaus
,
who expects
AFMD
stock to
drop by 7%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Bradley Canino
Stifel Nicolaus
|
5
USD
Downside 7% |
1 month ago
Apr 1, 2024
|
Affimed Therapeutics (AFMD) PT Raised to $5 at Stifel
StreetInsider
|
|
Swayampakula Ramakanth
H.C. Wainwright
|
10
USD
Upside 87% |
1 month ago
Apr 1, 2024
|
Affimed price target raised to $10 from $5 at H.C. Wainwright
TheFly
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AFMD's stock price target?
Price Target
22.95
USD
According to Wall Street analysts, the average 1-year price target for
AFMD
is 22.95 USD
with a low forecast of 5.05 USD and a high forecast of 63 USD.
What is Affimed NV's Revenue forecast?
Projected CAGR
29%
For the last 8 years the
compound annual growth rate for
Affimed NV's revenue is
1%.
The projected
CAGR
for the next 3 years is
29%.
You don't have any saved screeners yet
